• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙酮尿症患儿及青年期脑白质和灰质的发育。

White and gray matter brain development in children and young adults with phenylketonuria.

机构信息

Department of Psychological & Brain Sciences, Campus Box 1125, Washington University, St. Louis, MO, United States.

Department of Psychological & Brain Sciences, Campus Box 1125, Washington University, St. Louis, MO, United States; Department of Biomedical Engineering, Washington University, St. Louis, MO, United States.

出版信息

Neuroimage Clin. 2019;23:101916. doi: 10.1016/j.nicl.2019.101916. Epub 2019 Jul 2.

DOI:10.1016/j.nicl.2019.101916
PMID:31491833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6627563/
Abstract

Phenylketonuria (PKU) is a recessive disorder characterized by disruption in the metabolism of the amino acid phenylalanine (Phe). Prior research indicates that individuals with PKU have substantial white matter (WM) compromise. Much less is known about gray matter (GM) in PKU, but a small body of research suggests volumetric differences compared to controls. To date, developmental trajectories of GM structure in individuals with PKU have not been examined, nor have trajectories of WM and GM been examined within a single study. To address this gap in the literature, we compared longitudinal brain development over a three-year period in individuals with PKU (n = 35; 18 male) and typically-developing controls (n = 71; 35 male) aged 7-21 years. Using diffusion tensor imaging (DTI) and structural magnetic resonance imaging (MRI), we observed whole-brain and regional WM differences between individuals with PKU and controls, which were often exacerbated with increasing age. In marked contrast with trajectories of WM development, trajectories of GM development did not differ between individuals with PKU and controls, indicating that neuropathology in PKU is more prominent in WM than GM. Within individuals with PKU, mediation analyses revealed that whole-brain mean diffusivity (MD) and regional MD in the corpus callosum and centrum semiovale mediated the relationship between dietary treatment compliance (i.e., Phe control) and executive abilities, suggesting a plausible neurobiological mechanism by which Phe control may influence cognitive outcomes. Our findings clarify the specificity, timing, and cognitive consequences of whole-brain and regional WM pathology, with implications for treatment and research in PKU.

摘要

苯丙酮尿症(PKU)是一种常染色体隐性遗传病,其特征是氨基酸苯丙氨酸(Phe)代谢紊乱。先前的研究表明,PKU 患者的大脑白质(WM)有明显的损伤。但关于 PKU 患者大脑灰质(GM)的研究相对较少,但有一些研究表明与对照组相比存在体积差异。迄今为止,尚未对 PKU 患者 GM 结构的发育轨迹进行研究,也没有在单一研究中研究 WM 和 GM 的轨迹。为了解决这一文献空白,我们比较了 35 名 PKU 患者(18 名男性)和 71 名正常发育对照者(35 名男性)在 7-21 岁期间的三年大脑纵向发育情况。使用弥散张量成像(DTI)和结构磁共振成像(MRI),我们观察到 PKU 患者和对照组之间存在全脑和区域 WM 差异,这些差异随着年龄的增长而加剧。与 WM 发育轨迹形成鲜明对比的是,PKU 患者和对照组之间的 GM 发育轨迹没有差异,这表明 PKU 中的神经病理学在 WM 中比 GM 更为突出。在 PKU 患者中,中介分析表明,全脑平均弥散度(MD)和胼胝体及半卵圆中心的区域 MD 介导了饮食治疗依从性(即 Phe 控制)与执行能力之间的关系,这表明 Phe 控制可能通过某种神经生物学机制影响认知结果。我们的研究结果阐明了全脑和区域 WM 病理学的特异性、时间进程和认知后果,对 PKU 的治疗和研究具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/11ecbddb7e20/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/e51d5eaa4cda/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/d2de62ba03e8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/11ecbddb7e20/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/e51d5eaa4cda/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/d2de62ba03e8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35be/6627563/11ecbddb7e20/gr3.jpg

相似文献

1
White and gray matter brain development in children and young adults with phenylketonuria.苯丙酮尿症患儿及青年期脑白质和灰质的发育。
Neuroimage Clin. 2019;23:101916. doi: 10.1016/j.nicl.2019.101916. Epub 2019 Jul 2.
2
Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.早期治疗的苯丙酮尿症患者灰质完整性的形态计量学分析。
Mol Genet Metab. 2016 May;118(1):3-8. doi: 10.1016/j.ymgme.2016.02.004. Epub 2016 Feb 16.
3
Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of the corpus callosum.年龄相关的儿童早发性和持续性苯丙酮尿症患者白质微观结构完整性下降:胼胝体的弥散张量成像研究。
Mol Genet Metab. 2010;99 Suppl 1(0 1):S41-6. doi: 10.1016/j.ymgme.2009.09.016.
4
White matter microstructural damage in early treated phenylketonuric patients.早期治疗苯丙酮尿症患者的脑白质微观结构损伤。
Orphanet J Rare Dis. 2018 Oct 26;13(1):188. doi: 10.1186/s13023-018-0912-5.
5
Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU).早期治疗苯丙酮尿症(PKU)个体的白质异常的内-外束分析。
Mol Genet Metab. 2021 Jan;132(1):11-18. doi: 10.1016/j.ymgme.2020.12.001. Epub 2020 Dec 5.
6
White matter integrity and executive abilities in individuals with phenylketonuria.苯丙酮尿症患者的脑白质完整性与执行能力。
Mol Genet Metab. 2013 Jun;109(2):125-31. doi: 10.1016/j.ymgme.2013.03.020. Epub 2013 Apr 6.
7
Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging.通过磁共振弛豫测量法和扩散张量成像对苯丙酮尿症患者白质改变的特征分析
Magn Reson Med. 2007 Dec;58(6):1145-56. doi: 10.1002/mrm.21422.
8
Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria.终生长期暴露于高水平且波动的苯丙氨酸会影响苯丙酮尿症患儿脑白质的完整性。
Mol Genet Metab. 2015 Jan;114(1):19-24. doi: 10.1016/j.ymgme.2014.11.007. Epub 2014 Nov 13.
9
Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome.经典型半乳糖血症中灰质和白质均受影响:神经影像学与临床结局相关性的探索性研究。
Mol Genet Metab. 2020 Dec;131(4):370-379. doi: 10.1016/j.ymgme.2020.11.001. Epub 2020 Nov 6.
10
Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria.脑白质完整性介导苯丙酮尿症患儿苯丙氨酸控制与执行能力之间的关系。
JIMD Rep. 2017;33:41-47. doi: 10.1007/8904_2016_579. Epub 2016 Jul 22.

引用本文的文献

1
White matter microstructure changes across the lifespan: a meta-analysis of longitudinal diffusion MRI studies.全生命周期的白质微观结构变化:纵向扩散磁共振成像研究的荟萃分析
bioRxiv. 2025 Aug 20:2025.08.15.669078. doi: 10.1101/2025.08.15.669078.
2
Diffusivity alterations related to cognitive performance and phenylalanine levels in early-treated adults with phenylketonuria.早期接受治疗的苯丙酮尿症成年患者中与认知表现及苯丙氨酸水平相关的扩散率改变
J Neurodev Disord. 2025 Jul 2;17(1):37. doi: 10.1186/s11689-025-09622-8.
3
Cognition and wellbeing in middle-aged early treated people with phenylketonuria: Preliminary results and methodological lessons.

本文引用的文献

1
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.成年苯丙酮尿症患者脑脊液生物胺耗竭与脑萎缩。
J Inherit Metab Dis. 2019 May;42(3):398-406. doi: 10.1002/jimd.12049. Epub 2019 Feb 1.
2
Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence.全球先天性代谢缺陷的出生率和死亡率:系统分析证据。
J Glob Health. 2018 Dec;8(2):021102. doi: 10.7189/jogh.08.021102.
3
Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria.
中年早治苯丙酮尿症患者的认知与幸福感:初步结果及方法学经验教训
Mol Genet Metab Rep. 2024 Nov 21;41:101160. doi: 10.1016/j.ymgmr.2024.101160. eCollection 2024 Dec.
4
Reversible white matter changes following a 4-week high phenylalanine exposure in adults with phenylketonuria.苯丙酮尿症成人患者在4周高苯丙氨酸暴露后出现的可逆性白质变化。
J Inherit Metab Dis. 2025 Jan;48(1):e12823. doi: 10.1002/jimd.12823. Epub 2024 Nov 27.
5
No Impairment in Bone Turnover or Executive Functions in Well-Treated Preschoolers with Phenylketonuria-A Pilot Study.苯丙酮尿症患儿经良好治疗后,骨代谢和执行功能无损害:一项初步研究。
Nutrients. 2024 Jun 28;16(13):2072. doi: 10.3390/nu16132072.
6
Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels.成年苯丙酮尿症患者的脑容量减少及其与血苯丙氨酸水平的关系。
J Neurodev Disord. 2024 Jun 21;16(1):33. doi: 10.1186/s11689-024-09553-w.
7
Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis.苯丙酮尿症患者的低骨矿化可能是由于未诊断出的代谢性酸中毒所致。
Mol Genet Metab Rep. 2023 Aug 9;36:100998. doi: 10.1016/j.ymgmr.2023.100998. eCollection 2023 Sep.
8
Compromised white matter is related to lower cognitive performance in adults with phenylketonuria.白质受损与苯丙酮尿症成人的较低认知表现有关。
Brain Commun. 2023 May 15;5(3):fcad155. doi: 10.1093/braincomms/fcad155. eCollection 2023.
9
Neurological and imaging phenotypes of adults with untreated phenylketonuria: new cases and literature review.未经治疗的苯丙酮尿症成人的神经和影像学表型:新病例和文献复习。
J Neurol. 2023 Aug;270(8):4060-4079. doi: 10.1007/s00415-023-11760-9. Epub 2023 May 10.
10
Characterisation and differential diagnosis of neurological complications in adults with phenylketonuria: literature review and expert opinion.成人苯丙酮尿症相关神经并发症的特征与鉴别诊断:文献回顾与专家意见
J Neurol. 2023 Aug;270(8):3675-3687. doi: 10.1007/s00415-023-11703-4. Epub 2023 Apr 20.
苯丙酮尿症患儿执行功能和语言能力的发育轨迹
Dev Neuropsychol. 2018;43(3):207-218. doi: 10.1080/87565641.2018.1438439. Epub 2018 Feb 12.
4
The complete European guidelines on phenylketonuria: diagnosis and treatment.《苯丙酮尿症的完整欧洲指南:诊断与治疗》。
Orphanet J Rare Dis. 2017 Oct 12;12(1):162. doi: 10.1186/s13023-017-0685-2.
5
Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.成人苯丙酮尿症认知与心理健康的长期随访:一项苯丙酮尿症-COBESO研究
Behav Genet. 2017 Sep;47(5):486-497. doi: 10.1007/s10519-017-9863-1. Epub 2017 Aug 3.
6
Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria.苯丙酮尿症患者中,盐酸沙丙蝶呤反应者与无反应者之间的治疗前认知和神经差异。
Mol Genet Metab Rep. 2017 Feb 23;12:8-13. doi: 10.1016/j.ymgmr.2017.01.013. eCollection 2017 Sep.
7
Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria.脑白质完整性介导苯丙酮尿症患儿苯丙氨酸控制与执行能力之间的关系。
JIMD Rep. 2017;33:41-47. doi: 10.1007/8904_2016_579. Epub 2016 Jul 22.
8
Phenylketonuria (PKU): A problem solved?苯丙酮尿症(PKU):问题解决了吗?
Mol Genet Metab Rep. 2015 Dec 29;6:8-12. doi: 10.1016/j.ymgmr.2015.12.004. eCollection 2016 Mar.
9
Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.早期治疗的苯丙酮尿症患者灰质完整性的形态计量学分析。
Mol Genet Metab. 2016 May;118(1):3-8. doi: 10.1016/j.ymgme.2016.02.004. Epub 2016 Feb 16.
10
The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.早期治疗的苯丙酮尿症患者白质异常的结局:一项回顾性纵向长期研究。
Mol Genet Metab. 2015 Nov;116(3):171-7. doi: 10.1016/j.ymgme.2015.08.005. Epub 2015 Aug 10.